[Pharmaceutical and Bio News] SK Bioscience signs contract for contract manufacturing of MSD Ebola vaccine
SK Bioscience announced a partnership with global pharmaceutical company MSD to participate in the development project for an Ebola vaccine supported by CEPI.
New Isolation Station in Schwabing: Here, Doctors Fight the Most Dangerous Pathogens
A newly modernized isolation station in Schwabing, Munich, is now equipped to treat highly contagious diseases such as Ebola and Lassa fever.
WARNING: A new Ebola-like virus is shaking the world
Public health experts warn that a serious disease from West Africa resembling Ebola may pose a global threat and recommend against traveling to regions where the disease spreads.
Africa: Ebola Has Gone From a Global Emergency to a Disease We Can Stop, Says CEPI Chief
Dr. Richard Hatchett, CEO of CEPI, highlights the significant advancements made in controlling Ebola but warns of ongoing challenges.